Description
HUMIRA is the only subcutaneous therapy approved by the US Food and Drug Administration (FDA) for the treatment of ulcerative colitis in paediatric patients aged five years and above.
$1,204.00
adalimumab
30 in stock
HUMIRA is the only subcutaneous therapy approved by the US Food and Drug Administration (FDA) for the treatment of ulcerative colitis in paediatric patients aged five years and above.
Weight | 0.1 kg |
---|
You must be logged in to post a review.
Reviews
There are no reviews yet.